Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONOGEST: Darunavir/Ritonavir Monotherapy in Pregnant Women With HIV-1
NCT02738502Phase 2Completed
- Sponsor
- ANRS
- Start
- Jul 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Started Jul 2016; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02738502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02738502.